西非慢性乙型肝炎病毒感染病例增加:联合治疗和免疫调节剂是最好的治疗方法吗?

Scott Godfred Yawson, Chinelo Noble Princess, Dauda Zakariya'u, Immanuel Azubuike
{"title":"西非慢性乙型肝炎病毒感染病例增加:联合治疗和免疫调节剂是最好的治疗方法吗?","authors":"Scott Godfred Yawson, Chinelo Noble Princess, Dauda Zakariya'u, Immanuel Azubuike","doi":"10.23937/2474-3658/1510294","DOIUrl":null,"url":null,"abstract":"West Africa has a high endemicity of chronic hepatitis B, which causes liver cancer, cirrhosis, liver failure, and chronic liver disease, all of which put a severe strain on the region's already crippled healthcare system. This disease kills nearly 200,000 people in West Africa each year. As a result, finding a cure is critical. Several scientists have developed potential treatments for this disease over the years. However, the majority of them have failed. In this paper, we shed more light on immunomodulators and combination therapy, two treatments that have shown promise in putting an end to this disease. We compared them to other modes of treatment currently available and explained why they are the best cure for chronic hepatitis B. We also encouraged the scientific community to conduct more research in this area so that better results can be realized as soon as","PeriodicalId":93465,"journal":{"name":"Journal of infectious diseases and epidemiology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Increasing Cases of Chronic Hepatitis B Virus Infection in West Africa: Is Combination Therapy and Immunomodulators the Best Cure?\",\"authors\":\"Scott Godfred Yawson, Chinelo Noble Princess, Dauda Zakariya'u, Immanuel Azubuike\",\"doi\":\"10.23937/2474-3658/1510294\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"West Africa has a high endemicity of chronic hepatitis B, which causes liver cancer, cirrhosis, liver failure, and chronic liver disease, all of which put a severe strain on the region's already crippled healthcare system. This disease kills nearly 200,000 people in West Africa each year. As a result, finding a cure is critical. Several scientists have developed potential treatments for this disease over the years. However, the majority of them have failed. In this paper, we shed more light on immunomodulators and combination therapy, two treatments that have shown promise in putting an end to this disease. We compared them to other modes of treatment currently available and explained why they are the best cure for chronic hepatitis B. We also encouraged the scientific community to conduct more research in this area so that better results can be realized as soon as\",\"PeriodicalId\":93465,\"journal\":{\"name\":\"Journal of infectious diseases and epidemiology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of infectious diseases and epidemiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23937/2474-3658/1510294\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of infectious diseases and epidemiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2474-3658/1510294","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
Increasing Cases of Chronic Hepatitis B Virus Infection in West Africa: Is Combination Therapy and Immunomodulators the Best Cure?
West Africa has a high endemicity of chronic hepatitis B, which causes liver cancer, cirrhosis, liver failure, and chronic liver disease, all of which put a severe strain on the region's already crippled healthcare system. This disease kills nearly 200,000 people in West Africa each year. As a result, finding a cure is critical. Several scientists have developed potential treatments for this disease over the years. However, the majority of them have failed. In this paper, we shed more light on immunomodulators and combination therapy, two treatments that have shown promise in putting an end to this disease. We compared them to other modes of treatment currently available and explained why they are the best cure for chronic hepatitis B. We also encouraged the scientific community to conduct more research in this area so that better results can be realized as soon as
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信